亚太地区白细胞去除术市场预测至 2028 年 - COVID-19 影响和按产品类型（白细胞去除术设备和白细胞去除术一次性用品）、应用（研究应用和治疗应用）和最终用户（血液成分提供商和血液中心、学术和研究机构）进行的区域分析、制药和生物技术公司以及医院和输血中心）
市场介绍
亚太地区白细胞去除术市场基于三个主要国家进行分析：中国、日本、印度、韩国、澳大利亚，以及亚太地区其他地区。中国在白细胞分离术市场的增长中贡献了主要份额。由于社会经济快速发展、环境问题、生活方式改变和城市化进程，中国在维护和改善人民健康方面面临诸多障碍。中国政府公布了“健康中国2030”规划纲要，强调健康对中国发展的战略重要性。 2018年，约有506,003个公立初级保健机构和约437,636个私人乡村诊所。 2018年，公立医院约1.2万家，私立医院（不含城市和社区医院）约2.1万家，其中非营利性医院约2.05万家，营利性医院约1.26万家。随着卫生领域投资的增加和白血病发病率的上升，中国正在衍生对白细胞分离术市场的需求。白血病患者常出现严重贫血和血小板减少症。目前临床上使用的白细胞分离机会导致红细胞和血小板快速丢失，增加出血风险，加剧贫血，降低后续化疗的效果。由于目前的白细胞去除方法需要增加全身血液循环，且时间较长，部分患者难以耐受。进一步改进白细胞分离机，实现快速、准确的白细胞分选，并最大限度地减少手术过程中可能出现的副作用，是亟待解决的问题。由于老年人口以及白血病病例的增加，医疗基础设施、新技术、研究和投资不断增加，正在为市场增长铺平道路。据 Globocan 称，预计到 2029 年，中国急性淋巴细胞白血病病例将增加 14,000 多例。
亚太地区国家正面临着由于 COVID-19 发病率不断上升的挑战。 COVID-19 大流行给世界许多国家的卫生系统带来了巨大压力。截至 2021 年 1 月 19 日，印度的 COVID-19 病例已达 10,582,647 例，总死亡人数超过 152,000 人。目前尚无经过验证的具体治疗方法，多种新型和改造分子正在研发中。在实验基础上使用。缺乏有效的治疗方案一直是我们缓解大流行病措施的主要障碍。有一些竞争药物，包括疟疾药物羟氯喹（一种抗病毒药物瑞德西韦）和伊维菌素（一种用于治疗蠕虫和其他寄生虫的药物），但结果并不令人鼓舞，有时甚至是相互矛盾的。在此背景下，血浆疗法被视为印度 COVID-19 患者的治疗方法。此外，上个月，特里苏尔附近的 GMCH 安装了执行单采手术的医疗设备，该技术首次在喀拉拉邦用于为一名 51 岁男子注射血浆。单采手术由 GMC 的技术人员与医学、输血医学和麻醉部门合作进行。
市场概况和动态
亚太地区白细胞分离术市场预计将从2021年的1469万美元增长到2028年的2791万美元；预计2021年至2028年复合年增长率为9.6%。输血是各国国家卫生基础设施和政策的组成部分。医疗行业的进步导致严重疾病和伤害的治疗程序得到改善，最终推动了患者对输血的需求。生存。人们越来越认识到医疗保健服务中输血和血液供应的重要性，导致愿意为医疗原因献血的人数增加。根据世界卫生组织 (WHO) 的数据，2018 年全球报告的献血量约为 1.174 亿次。献血者通常分为自愿无偿献血者、有偿献血者和家庭/替代献血者，根据 WHO 的说法，自愿/无偿献血者分为自愿/无偿献血者和无偿献血者。是可靠和充足血液供应的主要来源。根据世界卫生组织2019年数据，2008年至2015年，全球139个国家的自愿无偿献血者增加了1160万人次。在低收入和中等收入国家，献血的趋势也越来越突出。根据 2017 年 CAG 年会期间提供的数据，2016 年对 1,087 名患者进行了约 13,000 例手术。许多国家制定和推出的国家计划进一步吸引了大量的血小板和血液捐献者。例如，在印度，国家输血委员会 (NBTC) 隶属于国家艾滋病控制组织 (NACO)，是与国家输血委员会 (SBTC) 协调的中央机构，国家输血委员会 (SBTC) 隶属于国家艾滋病控制协会 (SACS)。 ）。 NBTC 支持与输血服务 (BTS) 相关的各种活动的健康计划。因此，世界各地合格捐献者数量的不断增加，促进了对用于分离所需血液成分的白细胞分离设备的需求。
主要细分市场
从产品类型来看，2021年白细胞分离一次性用品细分市场占有较大份额。从应用来看，2021年研究应用细分市场占有最大份额。基于最终用户，血液成分提供商和血液中心细分市场在 2021 年占据最大份额。
主要来源和上市公司
<准备本亚太地区白细胞分离术市场报告时参考的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有：旭化成株式会社；费森尤斯公司两合公司；血液公司；泰尔茂公司； STEMCELL 技术公司；赫马护理；玛科制药公司；所有细胞；干快递；和 BioIVT 等。购买报告的理由
- 了解亚太地区白细胞分离术市场格局，并确定最有可能保证强劲回报的细分市场
- 通过了解不断变化的形势，保持领先地位亚太地区白细胞去除术市场的竞争格局
- 通过识别最有可能销售的细分市场，有效规划亚太地区白细胞去除术市场的并购和合作交易
- 帮助做出明智的业务决策通过对亚太地区白细胞分离术市场各个细分市场表现的敏锐和全面的分析
- 获得亚太地区各个细分市场2021-2028年的市场收入预测。 li>
亚太地区白细胞分离术市场细分
亚太地区白细胞去除术市场 –按产品类型
- 白细胞去除一次性用品
- 白细胞去除设备
亚洲太平洋白细胞分离术市场 –按应用划分
- 研究应用
- 治疗应用
亚太地区白细胞去除术市场 –按产品类型
- 血液成分提供商和血液中心
- 医院和输血中心
- 制药和生物技术公司
- 学术和研究机构
亚太白细胞分离市场 -按国家/地区
- 中国
- 日本
- 印度
- 韩国
- 澳大利亚
- 亚太地区其他地区
亚太地区白细胞分离市场 -提及的公司
- 旭化成株式会社
- Fresenius SE & ;
- Haemonetics Corporation
- 泰尔茂株式会社
- STEMCELL Technologies Inc. ;
- HemaCare
- Macopharma
- AllCells
- STEMEXPRESS
- BioIVT
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Leukapheresis Market – By Product Type
1.3.2 Asia Pacific Leukapheresis Market – By Application
1.3.3 Asia Pacific Leukapheresis Market – By End User
1.3.4 Asia Pacific Leukapheresis Market – By Country
2. Asia Pacific Leukapheresis Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Leukapheresis – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinions
5. Asia Pacific Leukapheresis Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Expanding Number of Voluntary Blood Donors
5.1.2 Up-Scaling Incidence of Hematologic Diseases
5.1.3 Growing Elderly Population
5.2 Key Market Restraints
5.2.1 Expensive Cost of Leukapheresis
5.3 Key Market Opportunities
5.3.1 Heighten opportunities in Emerging Economies
5.4 Future Trends
5.4.1 Expansion in Therapeutic Apheresis
5.5 Impact Analysis
6. Asia Pacific Leukapheresis – Market Analysis
6.1 Asia Pacific Leukapheresis Market Revenue Forecast and Analysis
7. Asia Pacific Leukapheresis Market Analysis – by Product Type
7.1 Overview
7.2 Asia Pacific Leukapheresis Market Share by Product Type 2021 & 2028 (%)
7.3 Leukapheresis Devices
7.3.1 Overview
7.3.2 Leukapheresis Devices Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Apheresis Devices
7.3.2.1.1 Overview
7.3.2.1.2 Apheresis Devices Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Leukapheresis ColuMillions and Cell Separators
7.3.2.2.1 Overview
7.3.2.2.2 Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.3 Leukoreduction Filters
7.3.2.3.1 Overview
7.3.2.3.2 Leukoreduction Filters Market Revenue and Forecast to 2028 (US$ Million)
7.4 Leukapheresis Disposables
7.4.1 Overview
7.4.2 Leukapheresis Disposables Market Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Leukapheresis Market Analysis – by Application
8.1 Overview
8.2 Asia Pacific Leukapheresis Market Share by Application 2021 & 2028 (%)
8.3 Research Applications
8.3.1 Overview
8.3.2 Research Applications Market Revenue and Forecast to 2028 (US$ Million)
8.4 Therapeutic Applications
8.4.1 Overview
8.4.2 Therapeutic Applications Market Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Leukapheresis Market Analysis – by End-User
9.1 Overview
9.2 Asia Pacific Leukapheresis Market Share by End-User 2021 & 2028 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies Market Revenue and Forecast to 2028 (US$ Million)
9.4 Blood Component Providers and Blood Centers
9.4.1 Overview
9.4.2 Blood Component Providers and Blood Centers Market Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes Market Revenue and Forecast to 2028 (US$ Million)
9.6 Hospitals and Transfusion Centers
9.6.1 Overview
9.6.2 Hospitals and Transfusion Centers Market Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Leukapheresis Market – Country Analysis
10.1 Overview
10.1.2 Asia Pacific: Leukapheresis Market, by Country, 2021 & 2028 (%)
10.1.2.1 China: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 Overview
10.1.2.1.2 China: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 China: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.2.1.3.1 China: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.2.1.4 China: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.2.1.5 China: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.2.2 Japan: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Overview
10.1.2.2.2 Japan: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 Japan: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.2.2.3.1 Japan: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.2.2.4 Japan: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.2.2.5 Japan: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.2.3 India: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Overview
10.1.2.3.2 India: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 India: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.2.3.3.1 Canada: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.2.3.4 India: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.2.3.5 India: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.2.4 Australia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.1 Overview
10.1.2.4.2 Australia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.3 Australia: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.2.4.3.1 Australia: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.2.4.4 Australia: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.2.4.5 Australia: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.2.5 South Korea: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.5.1 Overview
10.1.2.5.2 South Korea: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.5.3 South Korea: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.2.5.3.1 South Korea: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.2.5.4 South Korea: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.2.5.5 South Korea: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.2.6 Rest of Asia Pacific: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Asia Pacific: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.6.3 Rest of Asia Pacific: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.2.6.3.1 Rest of Asia Pacific: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.2.6.4 Rest of Asia Pacific: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.2.6.5 Rest of Asia Pacific: Leukapheresis Market, by End User, 2019–2028 (USD Million)
11. Asia Pacific Leukapheresis Market – Impact of COVID-19 Pandemic
11.1 Impact Assessment of COVID-19 Pandemic
12. Asia Pacific Leukapheresis Market – Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Asahi Kasei Corporation
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Fresenius SE & Co. KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Haemonetics Corporation
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Terumo Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 STEMCELL Technologies Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 HemaCare
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Macopharma
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AllCells
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 STEMEXPRESS
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 BioIVT
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. China: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 2. China Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 3. China Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. China: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. Japan: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)
Table 6. Japan Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 7. Japan Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. Japan: Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. India: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)
Table 10. India Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 11. India Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. India: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Australia: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 14. Australia Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 15. Australia Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Australia: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 17. South Korea: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 18. South Korea Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 19. South Korea Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 20. South Korea: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of Asia Pacific: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of Asia Pacific Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Asia Pacific Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of Asia Pacific: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 25. Organic Developments Done by Companies
Table 26. Inorganic Developments Done by Companies
Table 27. Glossary of Terms, Leukapheresis Market
LIST OF FIGURES
Figure 1. Asia Pacific Leukapheresis Market Segmentation
Figure 2. Asia Pacific Leukapheresis Market Segmentation, By country
Figure 3. Asia Pacific Leukapheresis Market Overview
Figure 4. Leukapheresis Disposables Segment Held Largest Share of Leukapheresis Market
Figure 5. China to Show Significant Growth During Forecast Period
Figure 6. Asia Pacific Leukapheresis Market, Industry Landscape
Figure 7. Asia Pacific PEST Analysis
Figure 8. Asia Pacific Leukapheresis market impact analysis of driver and restraints
Figure 9. Asia Pacific Leukapheresis Market – Revenue Forecast and Analysis to 2021-2028
Figure 10. Asia Pacific Leukapheresis Market Share by Product Type 2021 & 2028 (%)
Figure 11. Leukapheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Apheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Leukoreduction Filters Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. Leukapheresis Disposables Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Asia Pacific Leukapheresis Market Share by Application 2021 & 2028 (%)
Figure 18. Research Applications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Therapeutic Applications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Asia Pacific Leukapheresis Market Share by End-User 2021 & 2028 (%)
Figure 21. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Blood Component Providers and Blood Centers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Academic and Research Institutes Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Hospitals and Transfusion Centers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Asia Pacific: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)
Figure 26. Asia Pacific: Leukapheresis Market, by Country, 2021 & 2028 (%)
Figure 27. China: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Japan: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. India: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Australia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. South Korea: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Rest of Asia Pacific: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- Asahi Kasei Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc.
- HemaCare
- Macopharma
- AllCells
- STEMEXPRESS
- BioIVT
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific leukapheresis market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific leukapheresis market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the leukapheresis market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution